Display options
Cite
Ataeinia B, Loberg C, Kravets H, et al. Successful palliative peptide receptor radionuclide therapy for impending compression of vena cava due to unresectable liver metastasis of neuroendocrine tumor. EXCLI J. 2019;18:273-276doi: 10.17179/excli2019-1220.
Ataeinia, B., Loberg, C., Kravets, H., Beheshti, M., von Mallek, D., Mottaghy, F. M., & Heinzel, A. (2019). Successful palliative peptide receptor radionuclide therapy for impending compression of vena cava due to unresectable liver metastasis of neuroendocrine tumor. EXCLI journal, 18273-276. https://doi.org/10.17179/excli2019-1220
Ataeinia, Bahar, et al. "Successful palliative peptide receptor radionuclide therapy for impending compression of vena cava due to unresectable liver metastasis of neuroendocrine tumor." EXCLI journal vol. 18 (2019): 273-276. doi: https://doi.org/10.17179/excli2019-1220
Ataeinia B, Loberg C, Kravets H, Beheshti M, von Mallek D, Mottaghy FM, Heinzel A. Successful palliative peptide receptor radionuclide therapy for impending compression of vena cava due to unresectable liver metastasis of neuroendocrine tumor. EXCLI J. 2019 May 21;18:273-276. doi: 10.17179/excli2019-1220. eCollection 2019. PMID: 31338000; PMCID: PMC6635723.
Copy Download .nbib Format: NLM
Share it on

EXCLI J. 2019 May 21;18:273-276. doi: 10.17179/excli2019-1220. eCollection 2019.

Successful palliative peptide receptor radionuclide therapy for impending compression of vena cava due to unresectable liver metastasis of neuroendocrine tumor.

EXCLI journal

Bahar Ataeinia, Christina Loberg, Hanna Kravets, Mohsen Beheshti, Dirk von Mallek, Felix M Mottaghy, Alexander Heinzel

Affiliations

  1. Department of Nuclear Medicine, University Hospital RWTH Aachen, Aachen, Germany.
  2. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  3. Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.

PMID: 31338000 PMCID: PMC6635723 DOI: 10.17179/excli2019-1220

Abstract

We present the case of a 77 year old male patient with metastatic pancreatic neuroendocrine tumor (NET). The patient was initially treated by extensive surgical resection that however, led to severe complications with delayed recovery. During follow-up, a number of new liver metastases were detected, one of which was in segment I with impending compression of the inferior vena cava. Due to age and general condition of the patient, instead of further surgical treatment, the patient received four cycles of

Keywords: 177Lu-DOTATOC; PRRT; metastasis; neuroendocrine tumors

References

  1. Radiographics. 1992 Mar;12(2):309-22 - PubMed
  2. Arch Surg. 2011 Jun;146(6):724-32 - PubMed
  3. Neuroendocrinology. 2012;95(2):157-76 - PubMed
  4. Expert Rev Gastroenterol Hepatol. 2012 Jun;6(3):357-69 - PubMed
  5. Semin Intervent Radiol. 2017 Dec;34(4):398-408 - PubMed
  6. Z Gastroenterol. 2018 Jun;56(6):583-681 - PubMed
  7. J Emerg Trauma Shock. 2018 Apr-Jun;11(2):146-148 - PubMed

Publication Types